Manipal Health Enterprises stock trades at ₹651 level after 11% premium debut
The stock began trading at ₹655 against the IPO price of ₹590 on the BSE
Manipal Health Enterprises, a Bengaluru-based company, saw its stock trade at an 11% premium on its debut, trading at ₹651 after listing at ₹655 on the BSE and ₹652 on the NSE. The IPO, valued at over ₹77,600 crore, was subscribed 4.92 times, with retail investors making up 93% of the demand. While the premium reflects strong investor interest, analysts advise caution, recommending a stop-loss at ₹620 and suggesting that fresh investors should wait for better entry levels or further debt reduction before purchasing.
Brief written by urgent.news from Hindu BusinessLine's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
